Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HIMA Looking To Jumpstart Japanese To Action In Reimbursement Arena

This article was originally published in The Gray Sheet

Executive Summary

Slow implementation of medical device reimbursement reforms agreed to by the Japanese government has prompted the Health Industry Manufacturers Association to highlight the issue for Deputy U.S. Trade Representative Richard Fisher in deregulation talks scheduled March 21-22 in Tokyo.

You may also be interested in...



Japan MHW To Set Payment Scheme, Reimbursement Levels By September

Japan's Ministry of Health and Welfare is expected to notify U.S. manufacturers the first week of September of the amount by which their devices will be reimbursed under the country's reorganized payment scheme, which is set to take effect on Oct. 1.

Japan MHW To Set Payment Scheme, Reimbursement Levels By September

Japan's Ministry of Health and Welfare is expected to notify U.S. manufacturers the first week of September of the amount by which their devices will be reimbursed under the country's reorganized payment scheme, which is set to take effect on Oct. 1.

Japan Agrees To Reimburse Improved Devices Within Four Months - USTR

The Japanese government has agreed to provide provisional reimbursement for incrementally improved medical technology products within four months of application, Deputy U.S. Trade Representative Richard Fisher told the House Medical Technology Caucus May 17.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013114

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel